Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cosford

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Beilstein Journal of Organic Chemistry|June 15, 2013
Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)Allison S Limpert, Margrith E Mattmann, Nicholas D P Cosford
Tetrahedron|February 2, 2019
A Combination of Flow and Batch Mode Processes for the Efficient Preparation of mGlu<sub>2/3</sub> Receptor Negative Allosteric Modulators (NAMs)Raveendra Panickar Dhanya, Ananda Herath, Douglas J Sheffler, et al.
F1000Research|May 23, 2017
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteinsDarren Finlay, Peter Teriete, Mitchell Vamos, et al.
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsyNicholas D P Cosford, Peter T Meinke, Kenneth A Stauderman, et al.
ACS Chemical Neuroscience|August 4, 2012
Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulatorsDouglas J Sheffler, Anthony B Pinkerton, Russell Dahl, et al.
Biological Psychiatry|April 10, 2018
Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical EfficacySamuel A Barnes, Douglas J Sheffler, Svetlana Semenova, et al.
Neuropharmacology|July 28, 2004
Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signalingAleksandra Klodzinska, Ewa Tatarczyńska, Ewa Chojnacka-Wójcik, et al.
International Journal of Experimental Pathology|September 4, 2013
Amphiphilic suramin dissolves Matrigel, causing an 'inhibition' artefact within in vitro angiogenesis assaysNatalie L Prigozhina, Andrew J Heisel, Jordan R Seldeen, et al.
Journal of Visualized Experiments : Jove|August 4, 2020
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase InhibitorsLester J Lambert, Celeste Romero, Douglas J Sheffler, et al.
Bio-Protocol|October 17, 2022
Protein Tyrosine Phosphatase Biochemical Inhibition AssaysMarek R Baranowski, Jiaqian Wu, Ye Na Han, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Beilstein Journal of Organic Chemistry|June 15, 2013
Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)Allison S Limpert, Margrith E Mattmann, Nicholas D P Cosford
Tetrahedron|February 2, 2019
A Combination of Flow and Batch Mode Processes for the Efficient Preparation of mGlu<sub>2/3</sub> Receptor Negative Allosteric Modulators (NAMs)Raveendra Panickar Dhanya, Ananda Herath, Douglas J Sheffler, et al.
F1000Research|May 23, 2017
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteinsDarren Finlay, Peter Teriete, Mitchell Vamos, et al.
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsyNicholas D P Cosford, Peter T Meinke, Kenneth A Stauderman, et al.
ACS Chemical Neuroscience|August 4, 2012
Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulatorsDouglas J Sheffler, Anthony B Pinkerton, Russell Dahl, et al.
Biological Psychiatry|April 10, 2018
Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical EfficacySamuel A Barnes, Douglas J Sheffler, Svetlana Semenova, et al.
Neuropharmacology|July 28, 2004
Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signalingAleksandra Klodzinska, Ewa Tatarczyńska, Ewa Chojnacka-Wójcik, et al.
International Journal of Experimental Pathology|September 4, 2013
Amphiphilic suramin dissolves Matrigel, causing an 'inhibition' artefact within in vitro angiogenesis assaysNatalie L Prigozhina, Andrew J Heisel, Jordan R Seldeen, et al.
Journal of Visualized Experiments : Jove|August 4, 2020
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase InhibitorsLester J Lambert, Celeste Romero, Douglas J Sheffler, et al.
Bio-Protocol|October 17, 2022
Protein Tyrosine Phosphatase Biochemical Inhibition AssaysMarek R Baranowski, Jiaqian Wu, Ye Na Han, et al.
Pageof 11